Diet drug Contrave to get another shot at FDA approval

Diet drug Contrave to get another shot at FDA approval

In June and July of 2012, the FDA approved the marketing of Belviq and Qsymia. But Contrave, the first of the three to come before the agency for approval, was rebuffed by the FDA in February 2011. Its sponsor, LaJolla-based biotech firm Orexigen 

6
Like
Save

Comments

Write a comment

*